Physician
Hutchinson Clinic, P.A., INC.
Hutchinson Clinic, P.A., INC. was paid $5.15M by Medicaid between Jan 2018 and Nov 2024, across 157 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 16% of everything it billed.
33Billing provider infoHUTCHINSON CLINIC, P.A., INC.
HUTCHINSON, KS 67502
HUTCHINSON, KS 67502
33aNPI1043298474assigned 01/05/2006
33bProvider typeInternal Medicine Physician
28Total paid$5.15M
24GClaims233,537
24DCodes billed157
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in Kansas
Rank by total paid#1 of 67
Median peer was paid$12K
This provider vs. median439×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,817 | $424K | |
| 2019 | 30,312 | $679K | |
| 2020 | 23,508 | $638K | |
| 2021 | 23,247 | $634K | |
| 2022 | 49,962 | $1.02M | |
| 2023 | 49,000 | $980K | |
| 2024incomplete | 35,691 | $780K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 28,452 | 26,681 | $802K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 14% | 4,185 | 2,941 | $707K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 23,515 | 21,988 | $515K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.6% | 5,577 | 5,421 | $495K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 4.9% | 2,170 | 2,114 | $250K |
| J2357 | Injection, omalizumab, 5 mg | 4.8% | 172 | 142 | $245K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.1% | 2,547 | 2,517 | $214K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 4,545 | 4,473 | $173K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 3.1% | 1,161 | 1,058 | $162K |
| 95117 | 2.3% | 9,542 | 5,646 | $117K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 5,195 | 2,292 | $115K |
| 94060 | 2.2% | 3,372 | 3,306 | $112K |
145 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.8% | 1,759 | $92K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.7% | 1,318 | $87K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 8,480 | $83K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.6% | 751 | $80K |
| 92587 | 1.5% | 3,664 | $75K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 3,261 | $72K |
| 92567 | 1.3% | 4,708 | $66K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,327 | $51K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,293 | $37K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 873 | $36K |
| 20610 | <1% | 1,087 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,473 | $28K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 41 | $24K |
| 93000 | <1% | 2,334 | $24K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 376 | $22K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 100 | $21K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,100 | $20K |
| J0897 | Injection, denosumab, 1 mg | <1% | 59 | $20K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 262 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,971 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,686 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 601 | $16K |
| 99205 | Prolong outpt/office vis | <1% | 170 | $15K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 948 | $15K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 621 | $15K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 308 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 467 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,705 | $10K |
| 99201 | <1% | 402 | $10K | |
| 90961 | <1% | 485 | $10K | |
| 73630 | <1% | 639 | $9K | |
| 74018 | <1% | 713 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 510 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 509 | $9K |
| 84439 | <1% | 1,145 | $8K | |
| 82728 | <1% | 463 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,069 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 149 | $6K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 89 | $6K |
| 87481 | <1% | 637 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 385 | $6K |
| 87660 | <1% | 301 | $6K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 478 | $5K |
| 87634 | <1% | 79 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 27 | $4K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 592 | $4K |
| 81001 | <1% | 1,082 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 99 | $4K |
| 80069 | <1% | 1,038 | $3K | |
| 92588 | <1% | 58 | $3K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 178 | $3K |
| 97161 | <1% | 104 | $3K | |
| 71250 | <1% | 46 | $3K | |
| 85027 | <1% | 441 | $3K | |
| 99460 | <1% | 44 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 204 | $3K |
| 17110 | <1% | 54 | $3K | |
| 90686 | <1% | 155 | $2K | |
| 51798 | <1% | 373 | $2K | |
| 87510 | <1% | 301 | $2K | |
| 87480 | <1% | 301 | $2K | |
| 11721 | <1% | 1,243 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 378 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 388 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 177 | $2K |
| 73610 | <1% | 124 | $2K | |
| 85652 | <1% | 1,091 | $2K | |
| 73564 | <1% | 84 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 25 | $2K |
| 83540 | <1% | 862 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 37 | $2K |
| 93296 | <1% | 124 | $2K | |
| 83970 | <1% | 231 | $1K | |
| 52000 | <1% | 27 | $1K | |
| 84702 | <1% | 165 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 337 | $1K |
| 42830 | <1% | 12 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 446 | $1K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 27 | $988.06 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29 | $986.58 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | $964.00 |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $953.50 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $881.59 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 25 | $849.04 |
| 92557 | <1% | 24 | $796.15 | |
| 96160 | <1% | 64 | $790.97 | |
| 80061 | Lipid panel | <1% | 67 | $788.84 |
| 95115 | <1% | 70 | $729.11 | |
| 86780 | <1% | 70 | $728.90 | |
| 93227 | <1% | 56 | $716.15 | |
| 92504 | <1% | 71 | $677.18 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 49 | $653.13 |
| 69210 | <1% | 39 | $593.01 | |
| 85007 | <1% | 294 | $585.28 | |
| 0012A | <1% | 75 | $574.79 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 25 | $549.42 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 18 | $502.25 |
| 73130 | <1% | 28 | $483.75 | |
| 92555 | <1% | 41 | $459.48 | |
| 87150 | <1% | 12 | $418.68 | |
| 81025 | <1% | 62 | $406.77 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 26 | $362.75 |
| 87807 | <1% | 24 | $344.90 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 16 | $337.81 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 107 | $298.44 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $280.78 |
| 73110 | <1% | 15 | $267.18 | |
| 0011A | <1% | 83 | $256.27 | |
| 97802 | <1% | 14 | $255.28 | |
| V2020 | Frames, purchases | <1% | 19 | $225.60 |
| 96161 | <1% | 18 | $222.52 | |
| 92552 | <1% | 13 | $202.63 | |
| 93294 | <1% | 25 | $182.93 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,630 | $179.31 |
| 95251 | <1% | 30 | $175.96 | |
| 77080 | <1% | 25 | $160.97 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29 | $133.16 |
| 82746 | <1% | 12 | $123.55 | |
| 93017 | <1% | 15 | $111.10 | |
| 82607 | <1% | 13 | $108.26 | |
| 86850 | <1% | 14 | $74.66 | |
| 86762 | <1% | 13 | $74.66 | |
| 93016 | <1% | 16 | $68.93 | |
| 94729 | <1% | 13 | $68.58 | |
| 92015 | Determination of refractive state | <1% | 19 | $63.00 |
| 96127 | <1% | 28 | $61.46 | |
| 81003 | <1% | 44 | $60.93 | |
| 81002 | <1% | 27 | $24.91 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 172 | $20.91 |
| 20552 | <1% | 15 | $19.91 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 445 | $18.09 |
| 1159F | <1% | 22,296 | $0.02 | |
| 3008F | <1% | 6,840 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 213 | $0.01 |
| 3074F | 0% | 9,830 | $0.00 | |
| 3075F | 0% | 337 | $0.00 | |
| 3017F | 0% | 154 | $0.00 | |
| 99000 | 0% | 24 | $0.00 | |
| 3079F | 0% | 385 | $0.00 | |
| 3014F | 0% | 32 | $0.00 | |
| 4274F | 0% | 6,097 | $0.00 | |
| 3078F | 0% | 8,957 | $0.00 | |
| 4004F | 0% | 119 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHECK, MICHAEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Hutchinson Clinic, P.A. INC. | Hutchinson, KS | $9.02M |
| Hutchinson Clinic, PA, INC. | Hutchinson, KS | $1.06M |
| Hutchinson Clinic, P.A., INC. | South Hutchinson, KS | $314K |
| Hutchinson Physicians, P.A. | Hutchinson, KS | $36K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.